Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
enCore Combination Allograft
- Development stage
- Unknown
- Lead developer
- Osteogenics Biomedical
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Administration
- Implant
01
Overview
enCore Combination Allograft is a dental bone grafting material developed by Osteogenics Biomedical, consisting of a 50/50 mix of mineralized and demineralized cortical bone. This combination is designed to provide both a stable scaffold for osteoconduction (from the mineralized component) and osteoinductive potential (from the demineralized component, which exposes native bone morphogenetic proteins). It is primarily indicated for socket preservation, ridge augmentation, and guided bone regeneration (GBR) procedures to prevent alveolar bone loss following tooth extraction, thereby facilitating successful dental implant placement. In clinical studies conducted by the University of Michigan, it has been evaluated for its effectiveness in maintaining bone dimensions when used in conjunction with non-resorbable membranes during immediate implant placement in the esthetic zone.
- Brand names
- enCoreenCore Combination Allograft
- Other names
- enCore Combination AllograftBone graftAllograft
Beyond the preview
Go deeper on enCore Combination Allograft.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on enCore Combination Allograft.